Enantioselective synthesis of the complex rocaglate (-)-silvestrol.

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Abstract Text:

Baudouin Gerard,Regina Cencic,Jerry Pelletier,John A Porco,Baudouin Gerard,Regina Cencic,Jerry Pelletier,John A Porco,Baudouin Gerard,Regina Cencic,Jerry Pelletier,John A Porco,

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Publishing Authors By Initials

B Gerard,R Cencic,J Pelletier,JA Porco,B Gerard,R Cencic,J Pelletier,JA Porco,B Gerard,R Cencic,J Pelletier,JA Porco,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Angewandte Chemie (International ed. in English)

VOLUME: 46

Page Numbers: 7831-4

Journal Abbreviation: Angew. Chem. Int. Ed. Engl.

ISSN: 1433-7851

DAY: 10

MONTH: 10

YEAR: 2007

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370543

Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Enantioselective synthesis of the complex rocaglate (-)-silvestrol.

AFFILIATION: Department of Chemistry, Center for Chemical Methodology and Library Development, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA.

Country: Germany

AGENCY: United States NIGMS

GRANT: GM-073855

ACRONYM: GM

MEDLINETA: Angew Chem Int Ed Engl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Enantioselective synthesis of the complex rocaglate --silvestrol Related Publications

• 1,2-dihydroisoquinolines as templates for cascade reactions to access isoquinoline alkaloid frameworks.
• A biomimetic approach to the rocaglamides employing photogeneration of oxidopyryliums derived from 3-hydroxyflavones.
• An approach to skeletal diversity using functional group pairing of multifunctional scaffolds.
• Asymmetric syntheses of (-)-mitorubrin and related azaphilone natural products.
• Discovery of chemical reactions through multidimensional screening.
• Electron transfer-initiated Diels-Alder cycloadditions of 2'-hydroxychalcones.
• Enantioselective synthesis of bicyclo[2.2.2]octenones using a copper-mediated oxidative dearomatization/[4 + 2] dimerization cascade.
• Enantioselective synthesis of the complex rocaglate (-)-silvestrol.
• Extensively drug-resistant tuberculosis: new strains, new challenges.
• Integrating disease control strategies: balancing water sanitation and hygiene interventions to reduce diarrheal disease burden.
• Nucleophilic addition to N-phosphinylimines by rare-earth-metal triflate/trifluoroacetic anhydride activation.
• Preparation of alkylidene indane and related scaffolds and their further elaboration to novel chemotypes.
• Rapid access to polyprenylated phloroglucinols via alkylative dearomatization-annulation: total synthesis of (+/-)-clusianone(1).
• Skeletal diversity through radical cyclization of tetrahydropyridine scaffolds.
• Synthesis of carbamates and ureas using Zr(IV)-catalyzed exchange processes.
• Synthesis of pyrrolo-isoquinolines related to the lamellarins using silver-catalyzed cycloisomerization/dipolar cycloaddition.
• Synthesis of the azaphilones using copper-mediated enantioselective oxidative dearomatization.
• Synthesis of the epoxyquinol dimer RKB-3564 D: utilization of an alkoxysilanol to promote [4 + 4] dimerization.
• The equatorial ridges of Pan and Atlas: terminal accretionary ornaments?
• Total synthesis of the diazobenzofluorene antibiotic (-)-kinamycin C1.
• Total synthesis of the salicylate enamide macrolide oximidine II.